Related Experiment Video
Updated: Jan 2, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive
Hye Ryun Kim1, Hyo Jin Park2, Jimin Son2
1Yonsei Cancer Center, Division of Medical Oncology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-Gu, Seoul, 120-752, South Korea.
Regulatory T (Treg) cells suppress anti-tumor immunity by upregulating immune checkpoint molecules in the tumor microenvironment (TME). Targeting these molecules, particularly PD-1 on Treg cells, may enhance cancer treatment efficacy.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Regulatory T (Treg) cells play a crucial role in cancer immunosuppression.
- The precise mechanisms of Treg cell-mediated immunosuppression within the tumor microenvironment (TME) remain incompletely understood.
Purpose of the Study:
- To investigate the phenotypic and functional changes of T cell subsets, focusing on immune checkpoint (IC) molecule expression on Treg cells within the TME.
- To elucidate the mechanisms by which the TME influences Treg cell immunosuppressive activity.
Main Methods:
- Comparative analysis of T cell phenotypes, including Treg cells, from peripheral blood, malignant effusions, and tumors in 103 cancer patients.
- Detailed examination of IC-molecule expression (PD-1, TIM-3, TIGIT, CTLA-4) on Treg and conventional T (Tconv) cells from paired blood, peritumoral, and tumor tissues in 12 lung cancer patients.
- Functional assays in a mouse lung cancer model to assess immunosuppressive mechanisms of tumor-infiltrating Treg cells.
Main Results:
- Immune checkpoint (IC) molecule expression, especially PD-1, was progressively upregulated on CD8+, CD4+, and Treg cells as they approached the tumor.
- PD-1 expression was significantly higher on Treg cells compared to Tconv cells in lung cancer patients and in a mouse model.
- PD-1 high-expressing tumor-infiltrating Treg cells exhibited potent immunosuppressive activity, partially reversible with anti-PD-1 antibody blockade.
Conclusions:
- The tumor microenvironment (TME) induces immunosuppressive functions in Treg cells through upregulation of immune checkpoint (IC) molecules.
- Targeting IC molecules, such as PD-1, on Treg cells presents a promising therapeutic strategy for enhancing anti-tumor immunity in cancer treatment.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

